SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

BREAKING BOUNDARIES OF SCIENCE, TECHNOLOGY, MEDICINE, ART & HEALTHCARE POLICY

Scientific Committee

Over 20 Subcommittees powering the therapeutics and tech innovation research and initiatives.

Scientific Committee

The Alzheimer’s Disease and Dementia SBMT Subcommittee, focuses on research on novel early diagnostics, therapeutics and management of Alzheimer’s disease and neurodegenerative diseases and dementia.

The Autism and Pediatric Neuroscience SBMT Subcommittee focuses on research on autism spectrum disorder and pediatrics neurological diseases, their implications diagnostics and therapeutics.

The Cerebrovascular and Skull base Surgery SBMT Subcommittee encompasses the divisions of neurosurgery, interventional neuroradiology, and AI endovascular surgery, all of which focus on a multidisciplinary approach to the treatment and care of various neurovascular diseases.

The Epilepsy, EEG, MEG, and NeuroRadiology SBMT Subcommittee, focuses on the functional aspects of neuro-imaging and associated research. MRI, MEG, PET, nuclear medicine, MRSI, MR-PET, DTI, CT-PET, focused ultrasound, MSI/MEG, ultra-high and low field MRI and interventional radiology, neurooncology, SRS, Gamma-Knife, Cyberknife, ZAP.

The Military Medicine and Veterans Health focuses on research regarding health for wounded soldiers and improvement of quality of life. PTSD, Traumatic Brain Injury, Mental Health, Neurotechnology, prosthetics, and Neurotrauma.

The NanoneuroSurgery and NeuroPhotonics SBMT Subcommittee focuses on research on the newest advances on nanotechnology for the purpose of neurosurgery and neurology. This subcommittee also explores the novel phtotonic applications in neurology and neurosciences in general.

The Neurooncology and Stem Cell SBMT Subcommittee, focuses on research on Brain cancer such as Glioblastoma, Astrocytoma and Meningiomas, their early molecular diagnosis, different therapeutic modalities (chemotherapy, radiation oncology, biologics, immunotherapy)

The Neuropsychiatric and Innovation SBMT Subcommittee, focuses on research on addiction, anxiety disorder, autism, sleep, medical imaging for psychiatric conditions, schizophrenia, depression, PTSD.

The Neuroscience20 SBMT Initiative subcommittee focuses on the global economical burden of neurological diseases and formulates resolutions given to the G20 leaders. It also leads an annual summit that is a think tank that serves this purpose, engaging in business plan workshops, health care policy issues that affect treatment delivery, usage of certain devices/drugs/imaging technologies, FDA regulations and reimbursements, federal and regional regulation impacting health care delivery and research funding, initiative and congressional legislation.

The Neurotechnology, Brain Computer Interface and Neuroengineering SBMT Subcommittee is for those who want to see the future, today. It dwells on the latests technological advances applied to neurosciences in general. AI Machine Learning.

The Psychedelics SBMT Subcommittee, focuses on research on the use of psychedelics for diverse neuropsychiatric illnesses.

The Spine Surgery SBMT subcommittee focuses on State-of-the-art diagnostic, surgical tools, and therapeutics. Some topics that we research are:
• Degenerative spine disease
• Spinal deformity (kyphosis/scoliosis)
• Spinal tumors (primary and metastatic bone tumors as well as intradural tumors)
• Spinal trauma
• Osteoporotic and geriatric spinal pathology
• Revision spinal surgery to treat failed fusions or adjacent level pathology
• Intraoperative CT scan and navigation systems
• State-of-the-art neuromonitoring
• CyberKnife radiosurgery
We specialize in traditional open and newer minimally invasive spinal techniques to treat the above pathologies.

The Visual Processing and Retinal Neuromodulation SBMT Subcommittee focuses on research on retinal processing and its impact on modulation
of autonomic, endocrine and limbic functions, visual influence on movement and behavior (including mental health diagnoses), effect of delayed visual development in autism and other developmental disabilities, visual circuitry disruptions from autonomic dysregulation, concussions and other brain injuries, advancements in optical assessments, sensory integration, virtual augmented/mixed reality.

Vahid Mohammadzadeh

Visual Processing and Retinal Modulation Subcommittee SBMT 2023-2024
Glaucoma Clinical and Research Fellow, Stein Eye Institute, UCLA. 2- Glaucoma Research Fellow

Delia Cabrera Debuc

Visual Processing and Retinal Modulation Subcommittee SBMT 2023-2024
Dr. Cabrera DeBuc’s laboratory research focuses on developing methods and algorithms to quantify pathological features and treatment-induced changes in patients with ocular and neurological diseases. The primary focus is to develop quantitative tools to improve ocular imaging and image processing analysis for clinical use as well as to identify novel imaging biomarkers of the onset and progression of ophthalmic and neurological diseases using advanced optical imaging (e.g., OCTA, LSFG, RFI, cSLO). The lab also has an interest in developing and translating low-cost multimodal approaches for eye screening integrated with telemedicine and artificial intelligence applications in primary care and community settings.

Amy Pruszenski

Visual Processing and Retinal Modulation Subcommittee SBMT 2023-2024
Amy Pruszenski, OD, FCOVD graduated from the Massachusetts Institute of Technology in 1989 with a Bachelor of Science degree in Cognitive Science. She graduated from the New England College of Optometry in 1993. She has been providing Neuro-Developmental vision care for the past 23 years, collaborating with other health care providers to ensure a coordinated approach.

Pegah Khosravi

Epilepsy, EEG, MEG, and NeuroRadiology Subcommittee SBMT 2023-2024

Leslie Prichep

Epilepsy, EEG, MEG and NeuroRadiology Subcommittee SBMT 2023-2024

Marcos Wagner de Souza Porto

Advances in Cerebrovascular and Spine Subcommittees SBMT 2023-2024
We are in the neuromedical innovation area and are currently dedicated to the study of the role of cannabidiol in epilepsy and related areas. But we are available for inquiries in various areas of neuroscience – cerebral aneurysm, spinal column, dorsal part of the head, Alzheimer’s etc.

Amin Kassam

Chair of Cerebrovascular advances Subcommittee 2023-2024 | WBMF Pioneer in Technology Development Award Recipient, 2022
Over the past two decades, Dr. Kassam has been the Chairman or led four Neurosurgery programs; pioneered and globally taught novel surgical procedures; founded or held leadership roles in several technology start-up companies; and, has held executive health care administration leadership roles needed to translate these innovations through Integrated Service Line delivery models. He is the Founder and CEO of Neeka Enterprises and recently served as the Chief Scientific Strategist, VP Neurosciences, and Chairman of Neurological Surgery for AdvocateAurora Health Care. 

Keerthy Sunder

WBMF Golden Axon Leadership Award, 2023
CEO, Karma Doctors & Karma TMS, Inc Founder, The Sunder Foundation, Assistant Clinical Professor, University of California Riverside, CA, USA

Christopher Wheeler

WBMF Golden Axon Award, 2023 | Alzheimer's Disease and Dementia Subcommittee SBMT 2023- 2024
President at StemVax, Chief Scientific Officer at T-Neuro Pharma, Inc. Professor and research scientist at Cedars-Sinai Medical Center

Bryan Aroz

SBMT Global Event Director, 2020 Award Recipient | Neuroscience20 Event Director